Position in MRKR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$341
+$40 QoQ
Shares Held
232
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 35 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRKR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. MRKR ranks #379 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in MRKR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341 | 232 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $301 | 232 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $359 | 242 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $214 | 242 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $354 | 232 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $285 | 232 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $721 | 232 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $654 | 232 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,259 | 232 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,220 | 284 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,556 | 283 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,270 | 280 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $858 | 277 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $193 | 273 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $736 | 2,727 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,004 | 2,717 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $898 | 2,726 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,183 | 2,691 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,554 | 2,690 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,235 | 3,690 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,389 | 3,724 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,139 | 10,777 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $75,273 | 51,913 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $130,015 | 86,677 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $187,580 | 90,619 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $53,967 | 28,404 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||